WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

DESCRIPTION OF GUL-E-SURKH (ROSA DAMASCENA) IN UNANI MEDICINE: A REVIEW

Mohammad Shahabuddin*, Mohammad Idris, Shabir A. Bhat, M. Adnan, Farheen

ABSTRACT

Rosa damascena is one of the most important species of Rosaceae family and oldest plants under human cultivation. It is a beloved garden flower and a symbol of affection and honour for a wide range of human events in both celebratory and sombre because of its beauty and fragrance. Due to its specific fragrance, it is widely used in perfumery and cosmetic industry. Apart from aromatic uses of Gul-e- Surkh, it is commonly used for medicinal purposes in traditional streams of medicine. For instance, in Unani system of medicine, it has been used for centuries, and is being described in detail in ethnobotanical and Unani classical literature owing to its various therapeutic actions, such as laxative, analgesic, exhilarant, refrigerant, demulcent, astringent (in dry flowers), de-obstructant etc. Gul-e-Surkh, is not only used as a single medicinal agent, but a lot of Unani compound formulations and dosage forms are also used in such a way that as active ingredient or part of ingredients to obtain its therapeutic efficacy in a number of disorders/ diseases.

Keywords: Unani medicine, Gul-e-Surkh (Rosa damascena), Traditional medicine.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More